Comparing the Effect of Combining Exercise with Rosuvastatin versus Atorvastatin on Lipid Profile and Functional Capacity: A Retrospective Cohort Study
Table 1
Characteristics of patients included in the analyses according to statin type used.
Sociodemographic and clinical variables measured at admission
Atorvastatin users (106 patients)
Rosuvastatin users (176 patients)
value
No. (%) or
No. (%) or
Age (years)
0.94
Sex (male)
75 (70.8)
120 (68.2)
0.68
Tobacco smoking
Nonsmoker
54 (51.4)
83 (47.7)
0.54
Previous smoker
42 (40.0)
78 (44.8)
0.43
Current smoker
9 (8.6)
13 (7.5)
0.74
Weight (kg)
0.16
Blood pressure (mmHg)
Systolic BP
0.18
Diastolic BP
1.0
Lipids (mmol/L)
Total cholesterol
0.39
Triglycerides
0.14
LDL
0.002
HDL
0.03
HbA1c (mmol/mol)
0.95
HbA1c (%)
0.95
6-minute walk test (meters)
0.75
SF-36 score
0.42
Medications used
Cardiovascular medications
102 (96.2)
163 (92.6)
0.22
Anticoagulants
18 (17.0)
24 (13.6)
0.44
Antiplatelets
91 (85.9)
148 (84.1)
0.68
Other cholesterol-lowering medications
7 (6.6)
18 (10.2)
0.30
Oral antidiabetics
22 (20.8)
47 (26.7)
0.26
Insulin
7 (6.6)
16 (9.1)
0.46
Statin doses
Low to moderate intensity
33 (31.1)
72 (40.9)
0.09
High intensity
73 (68.9)
104 (59.1)
0.09
Exercise performed during the 12-week cardiac rehabilitation program
Total minutes of exercise
0.61
Adherence (%) to exercise schedule (weekly sessions performed/prescribed)
0.05
Average of weekly exercise minutes
0.69
HbA1c: glycated haemoglobin; SF-36: 36-Item Short-Form Health Survey; LDL: low-density lipoprotein; HDL: high-density lipoprotein; BP: blood pressure. Stone et al. [8].
